
Robert Smith, MD, Medical Director of Cathedral Village, introducing the Program
|
|
|
|
David Hoffman, Esq. of David Hoffman & Associates, PC opening the discussion of Psychotropic Medications and the Legal/Regulatory Perspective
|
|
|
Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD, Health Policy University of the Sciences, Mercy Life presenting the Physician Perspective on Psychotropic Use
|

|

|
Thomas C. Snader, PharmD, President, TCS Pharmacy Consultants presenting the Consultant Pharmacist’s Role in Assuring Appropriate Antipsychotic Use
|

|

|
Patrick Loughlin, MSW, LSW, Cathedral Village- Director of Supportive Services presenting the Role and Purpose of the Antipsychotic Medication Review Committee
|